Menu
Back to Journals » ImmunoTargets and Therapy » Volume 2
ImmunoTargets and Therapy
ISSN: 2253-1556
- View all (170)
- Volume 13, 2024 (15)
- Volume 12, 2023 (14)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Archive: Volume 2, 2013
T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management
Yoneda A, Jinushi M
ImmunoTargets and Therapy 2013, 2:135-141
Published Date: 21 November 2013
Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
Jolles S
ImmunoTargets and Therapy 2013, 2:125-133
Published Date: 19 September 2013
Therapeutic vaccines in non-small cell lung cancer
Socola F, Scherfenberg N, Raez LE
ImmunoTargets and Therapy 2013, 2:115-124
Published Date: 19 September 2013
Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease
Lambracht-Washington D, Rosenberg RN
ImmunoTargets and Therapy 2013, 2:105-114
Published Date: 12 August 2013
Identification, characterization, and synthesis of peptide epitopes and a recombinant six-epitope protein for Trichomonas vaginalis serodiagnosis
Alderete JF, Neace CJ
ImmunoTargets and Therapy 2013, 2:91-103
Published Date: 13 August 2013
Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities
Graves A, Hessamodini H, Wong G,Lim WH
ImmunoTargets and Therapy 2013, 2:73-90
Published Date: 23 July 2013
Allergen immunotherapy: routes, safety,efficacy, and mode of action
Hochfelder JL, Ponda P
ImmunoTargets and Therapy 2013, 2:61-71
Published Date: 23 July 2013
Immunotargeting in the management of psoriasis
Kaffenberger BH, Kaffenberger TM, Wong HK
ImmunoTargets and Therapy 2013, 2:51-60
Published Date: 1 July 2013
Update on the challenges and recent advances in cancer immunotherapy
Baronzio G, Parmar G, Shubina IZH, Cassutti V, Giuli S, Ballerini M, Kiselevsky M
ImmunoTargets and Therapy 2013, 2:39-49
Published Date: 17 June 2013
The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma
Briggs SEW, Gozzard P, Talbot DC
ImmunoTargets and Therapy 2013, 2:31-37
Published Date: 22 May 2013
Update on immunopathogenesis and immunotherapy in multiple sclerosis
Selter RC, Hemmer B
ImmunoTargets and Therapy 2013, 2:21-30
Published Date: 26 April 2013
Cancer testis antigen and immunotherapy
Krishnadas DK, Bai F, Lucas KG
ImmunoTargets and Therapy 2013, 2:11-19
Published Date: 18 April 2013
Immunotherapy in the management of melanoma: current status
Alston D, Brewer JD
ImmunoTargets and Therapy 2013, 2:1-10
Published Date: 26 February 2013